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Recent Trends in Euthanasia and Other End-of-Life Practices  
in Belgium
To the Editor: In Belgium, where euthanasia 
was legalized in 2002, large-scale repeat surveys 
have monitored the evolution of medical end-of-
life practices since 1998, with subsequent sur-
veys conducted in 2001 and 20071,2 and the latest 
in 2013.
As was done in previous surveys,2 we sent 
questionnaires to 6188 physicians certifying 
death certificates from the first half of 2013 in 
Flanders, the Dutch-speaking half of Belgium, 
with approximately 6 million inhabitants and 
58,000 deaths annually (see the Supplementary 
Appendix, available with the full text of this let-
ter at NEJM.org). The response rate was 60.6%. 
The response sample was weighted to be repre-
sentative of all the deaths that occurred in the 
first half of 2013.
After a large increase between 2001 and 2007, 
the total percentage of deaths preceded by one 
or more possibly life-shortening end-of-life prac-
tices remained stable at 47.8% in 2013 (Table 1). 
The intensified alleviation of pain and other 
symptoms with the use of drugs, with possible 
shortening of life taken into account (24.2% of 
deaths), and the withholding or withdrawing of 
life-prolonging treatment (17.2%) remained the 
most prevalent end-of-life practices.
The rate of euthanasia increased significantly 
between 2007 and 2013, from 1.9 to 4.6% of 
deaths. The overall increase relates to increases 
in both the number of requests (from 3.5 to 
6.0% of deaths) and the proportion of requests 
granted (from 56.3 to 76.8% of requests made).
After a decrease from 3.2% in 1998 to 1.8% 
in 2007, the rate of hastening death without an 
explicit request from the patient remained stable 
at 1.7% in 2013. After an increase from 8.2% in 
2001 to 14.5% in 2007, the rate of use of con-
tinuous deep sedation until death decreased to 
12.0% in 2013.
As compared with practices in 2007, decision 
making in euthanasia and physician-assisted 
suicide in 2013 more often included an oral and 
written request from the patient and consulta-
tion with another physician, both of which are 
requirements of the euthanasia law3 (Table S1 in 
the Supplementary Appendix). Palliative care 
services were involved in 73.7% of cases in 2013. 
These results suggest a stricter assessment of 
legal eligibility criteria in 2013 than in 2007. 
Decision making in other end-of-life practices 
also increasingly included patient and family 
input (data not shown).
We found an increased demand for euthana-
sia in Belgium between 2007 and 2013, as well 
as growing willingness among physicians to 
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meet those requests, mostly after the involve-
ment of palliative care services. This finding 
indicates that, after 11 years of experience, eu-
thanasia is increasingly considered as a valid 
option at the end of life in Belgium. For the first 
time, the rate of euthanasia in the Flanders area 
of Belgium is significantly higher than that in 
the Netherlands (2.8% in 2010).4
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Table 1. Prevalence of Euthanasia and Other End-of-Life Practices in Flanders, Belgium, in 1998, 2001, 2007, and 2013.*
Variable Survey Year P Value†
1998 2001 2007 2013
Total deaths annually — no. 56,354 55,793 54,881 61,621‡ —
Deaths in survey sample — no. 3999 5005 6202 6188 —
Response rate — % of physicians surveyed 48.1 58.9 58.4 60.6 —
Studied cases — no. 1925 2950 3623 3751 —
Death preceded by at least one end-of-life prac-
tice — % (95% CI)
39.3 (37.0–41.6) 38.4 (36.5–40.3) 47.8 (45.9–49.8) 47.8 (46.1–49.5) >0.99
Intensified alleviation of pain and other 
symptoms§
18.4 (16.6–20.4) 22.0 (20.5–23.6) 26.7 (25.1–28.4) 24.2 (22.9–25.7) 0.02
Withholding or withdrawing of life-prolong-
ing treatment
16.4 (14.7–18.3) 14.6 (13.2–16.0) 17.4 (15.9–19.0) 17.2 (15.9–18.6) 0.85
Physician-assisted death¶ 4.4 (3.5–5.5) 1.8 (1.4–2.4) 3.8 (3.2–4.5) 6.3 (5.6–7.1) <0.001
Euthanasia 1.1 (0.7–1.7) 0.3 (0.2–0.5) 1.9 (1.6–2.3) 4.6 (4.0–5.2) <0.001
Assisted suicide 0.12 (0.04–0.36) 0.01 (0.00–0.10) 0.07 (0.02–0.19) 0.05 (0.02–0.13) 0.97
% of deaths with request for eutha-
nasia or assisted suicide 
2.1 (1.6–2.9) —‖ 3.5 (3.0–4.1) 6.0 (5.3–6.7) <0.001
% of requests for euthanasia or as-
sisted suicide granted 
57.4 (41.0–72.4) NC 56.3 (48.2–64.0) 76.8 (71.2–81.6) <0.001
Hastening of death without explicit re-
quest from patient
3.2 (2.4–4.1) 1.5 (1.1–2.0) 1.8 (1.3–2.4) 1.7 (1.3–2.2) 0.84
Continuous deep sedation until death —  
% (95% CI)
—‖ 8.2 (7.1–9.4) 14.5 (13.1–15.9) 12.0 (10.9–13.2) 0.002
Patient decided to stop eating and drinking — 
% (95% CI)
—‖ —‖ —‖ 0.5 (0.3–0.7) NC
* Data regarding these practices are weighted percentages with 95% confidence intervals (CI). Analyses were performed with the use of the 
complex samples function of SPSS software, version 22.0 (IBM). NC denotes could not be calculated.
† Two-sided P values are for the comparison of 2007 data with 2013 data and were calculated with the use of Pearson’s chi-square test.
‡ Data are preliminary and unconfirmed, as reported by Statistics Belgium.
§ Intensified alleviation of pain and other symptoms was performed with the use of drugs, with possible shortening of life taken into ac-
count.
¶ Physician-assisted death was defined as the administration of drugs with the explicit intention of shortening life. Euthanasia was defined 
as physician-assisted death at the explicit request of the patient.
‖ The survey question was not asked in the respective year.
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Disclosure forms provided by the authors are available with 
the full text of this letter at NEJM.org.
This letter was published on March 17, 2015, at NEJM.org.
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Details about the methods of the study 
Death certificate survey 
We conducted a population-based death certificate survey identical to surveys in 1998, 2001 and 2007, based 
on a large and representative sample of deaths in Flanders, the semi-autonomous northern half of Belgium 
with approximately six million inhabitants and 58,000 deaths annually. A stratified random sample of deaths in 
2013 was drawn weekly at the Flemish Agency for Care and Health, the central administration authority for 
processing death certificates. All deaths from January 1
st
 until June 30
th
 2013 of Belgian residents aged one year 
or older were assigned to one of three strata, based on underlying cause of death as indicated on the death 
certificate and the estimated corresponding likelihood of an end-of-life decision. Sampling fractions for each 
stratum increased with this likelihood. In the first stratum, all deaths for which euthanasia was mentioned on 
the death certificate were sampled. In the second stratum, one third of all cancer deaths were sampled. In the 
third stratum, one in six deaths resulting from any other cause was sampled. This resulted in a sample of 6,871 
deaths, about 21% of all deaths in the studied period. 
Within two months of the death certifying physicians received a four-page questionnaire with an introductory 
letter containing patient identifiers. Physicians were requested to complete the questionnaire by consulting the 
patient’s medical file. If the certifying physician was not the treating physician, the questionnaire was passed 
on to the treating physician. One physician could receive participation requests for up to five decedents, with 
at most three reminders per death case. To guarantee absolute anonymity for participating physicians, a lawyer 
served as an intermediary between responding physicians, researchers and the Flemish Agency for Care and 
Health, ensuring that completed questionnaires could never be linked to a particular patient or physician. 
Returning the questionnaire was regarded as implicit consent of the physician to participate in the study. After 
data collection a one-page questionnaire was mailed to all non-responding physicians inquiring about reasons 
for not participating. The mailing and anonymity procedures were approved by the Ethical Review Board of the 
University Hospital of the Vrije Universiteit Brussel, the Belgian National Disciplinary Board of Physicians, and 
the Belgian Privacy Commission. 
Questionnaire 
The repeatedly validated questionnaire on end-of-life decision-making first asked whether death had been 
sudden and unexpected. If answered negatively – and an end-of-life decision could thus not be precluded – 
physicians were asked whether they had: (1) withheld or withdrawn life-prolonging medical treatment taking 
into account or explicitly intending hastening the patient’s death; (2) intensified the alleviation of pain and/or 
other symptoms with drugs taking into account or co-intending possible hastening of death; and (3) 
administered, supplied or prescribed drugs with the explicit intention of hastening death. If in the latter case 
the drugs had been administered at the patient’s explicit request, the act was classified as euthanasia or 
assisted suicide depending on whether the patient self-administered the drugs. If drugs were used with the 
same explicit intention to hasten death but without the patient’s explicit request, the act was classified as 
hastening death without explicit patient request. This can include cases where a patient request was not 
judged as explicit by the physician, where the request came from the family or where the physician acted out 
of compassion. 
If more than one end-of-life decision was made, the act that involved the most explicit life-shortening intention 
was used to classify the case. When two decisions with similar life-shortening intention were made, 
administering drugs prevailed over withholding or withdrawing treatment. Details about the decision-making 
process, the types of drugs used and the estimated degree of life shortening according to the physician were 
requested for the most important end-of-life decision. Further in the questionnaire, physicians were asked 
whether the patient had been deeply and continuously sedated until death, whether palliative care services 
had been involved at the end of life, whether the patient had made a request for euthanasia that was not 
granted and whether the patient had intentionally ended life without a physician’s involvement by stopping 
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eating and drinking, taking medication or otherwise. Demographic and clinical patient data were obtained from 
the death certificate data and linked anonymously after data collection. 
Analysis 
The response sample was first corrected for disproportionate stratification (by weighting each stratum to make 
the proportion in the response sample identical to the proportion in all deaths) and adjusted to be 
representative of all deaths in the first half of 2013 in terms of age, sex, marital status, province of death, cause 
of death and place of death (adjustments were needed for province of death and place of death). After this 
weighting procedure there were no significant differences between response sample and all deaths on any of 
these variables.  Final weights varied between 0.11 and 1.90. The same procedure was used in all survey years 
(in 1998 there was no disproportionate stratification). Weighted percentages, 95% confidence intervals and 
Chi² (two-sided) p-values were calculated with the complex samples function in SPSS 22.0. 
Supplementary results 
In cases resulting in euthanasia the request had been made both orally and in writing significantly more often 
in 2013 than in 2007 (62.8% vs. 43.1%, p<0.001) (Table S1). Another physician was consulted significantly more 
often in 2013 than in 2007 (92.6% vs. 83.2%, p=0.007). The decision was discussed with the family in 80.6% 
(95%CI 74.6-85.5) in 2013 compared with 77.4% in 2007. Neuromuscular relaxants and/or barbiturates were 
used to perform euthanasia in 64.8% in 2013 and in 52.1% in 2007, with benzodiazepines and/or opioids used 
in 32.6% and 46.2% respectively (p=0.137). No changes in estimated life-shortening were found. Palliative care 
services had been involved in 73.7% of euthanasia cases in 2013. 
 
Table S1 – Characteristics of performed euthanasia/assisted suicide in Flanders, Belgium 2007-2013* 
  2007 2013 Chi² p-value 
Unweighted no. of cases (n=142) (n=349)  
Explicit request from patient 100 100 - 
Form of the request   <.001 
  Only oral 50.1 (39.1-61.0) 30.5 (24.3-37.5)  
  Only in writing 6.4 (2.0-18.1) 1.2 (0.6-2.4)  
  Oral and in writing 43.1 (34.6-52.0) 62.8 (55.8-69.3)  
  Advance euthanasia directive 0.5 (0.1-3.4) 5.5 (3.0-9.7)  
Consultation with other physician 83.2 (70.9-91.0) 92.6 (88.3-95.3) .007 
Discussion with family 77.4 (65.9-85.8) 80.6 (74.6-85.5) .599 
Drugs used for euthanasia/assisted suicide .137 
  Neuromuscular relaxant and/or barbiturate(s) 52.1 (40.9-63.1) 64.8 (57.8-71.3)  
  Benzodiazepine(s) and/or opioid(s) 46.2 (35.3-57.5) 32.6 (26.3-39.6)  
  Other 1.7 (0.5-5.2) 2.6 (0.9-6.9)  
EsGmated degree of life shortening† .934 
  Probably none 1.7 (0.5-5.2) 1.7 (0.7-4.1)  
  Less than 24h 9.7 (5.9-15.6) 12.5 (8.5-18.1)  
  Less than 1 week 44.1 (33.3-55.4) 41.0 (34.4-48.0)  
  More than 1 week 44.5 (33.7-55.9) 44.8 (38.1-51.6)  
Palliative care services involved at end of life ‡ 73.7 (67.5-79.1) - 
* Weighted column percentages (95% confidence intervals).  
† EsGmated by the reporGng physician. 
‡ Not asked in 2007. 
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Study limitations 
Although our study uses a robust population-based sampling method, a number of study limitations have to be 
taken into account. While a fairly high response rate for physician surveys was achieved, we cannot exclude 
non-response bias. Yet analysis of non-response questionnaires revealed lack of time as the most frequent 
reason for non-participation. Recall bias may also have influenced results, even though physicians received the 
questionnaire no later than eight weeks after their patient’s death. The sensitivity of the survey topic may have 
introduced untruthful or socially desirable reporting, but this is likely to be insignificant given the explicit 
guarantee of anonymity and physicians being well-acquainted with the survey. 
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